Tähelepanu! Artikkel on enam kui 5 aastat vana ning kuulub väljaande digitaalsesse arhiivi. Väljaanne ei uuenda ega kaasajasta arhiveeritud sisu, mistõttu võib olla vajalik kaasaegsete allikatega tutvumine
Stem Cell Innovations and ALS Association announce collaboration
Houston TX- USA and Calabasas Hills- CA- USA - December 11-
2006 - Stem Cell Innovations- Inc. (SCLL.OB) and The ALS
Association- a non-profit health organization dedicated to finding
a cure for amyotrophic lateral sclerosis (ALS)- announced today a
two-year discovery alliance. Stem Cell Innovations (SCI) will
develop human motor neuron models based on its proprietary
PluriCell(TM) technology that can be used for high-throughput
screening. Subsequently- the cell models will be used by alliance
partner Galapagos to discover novel drug targets for ALS. Under the
terms of the agreement- SCI will receive 400-000 Euros ($512-000)
from The ALS Association- upon completion of certain milestones. In
addition- SCI has the option to further develop certain
cell-therapy applications based on results identified in the
program.
"The human motor neuron cultures derived from our PluriCellswill form the basis of this exciting alliance-" said Stem CellInnovations CEO Dr. James Kelly. "We are very pleased to becollaborating with The ALS Association and Galapagos on thisdiscovery project."
Seotud lood
Hea arst! Tule ja anna oma väärtuslik panus, et terviseraskustesse sattunud inimesed saaksid võimaluse elada võimalikult toimekat ja rahuldustpakkuvat elu!
Enimloetud
4
Viimased uudised
Hetkel kuum
Liitu uudiskirjaga
Telli uudiskiri ning saad oma postkasti päeva olulisemad uudised.
Tagasi Meditsiiniuudised esilehele